KEVIN REYES: Open Payments
NPI 1316364672 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 11 payments from 5 companies in 2025. Trend: 2023 $198 · 2024 $196 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| ABBVIE INC. | 5 | $98 |
| Almatica Pharma LLC | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
Products named: FASENRA, VRAYLAR, LOREEV XR, ABILIFY ASIMTUFII, REXULTI.
Industry payments across NV — which companies pay providers there.
